Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine Effect on Color Vision in Healthy Controls
NCT02613091Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of clemastine in multiple sclerosis (MS), sponsored by University of California, San Francisco. Primary endpoint: Cone contrast test at 3 weeks. Started Apr 2016; status: completed.
02
Drugs
clemastine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02613091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02613091.